Cargando…

Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses

BACKGROUND: We aimed to analyze the radiation dose and compare survival among combined modality therapy using modern radiation techniques for patients with esophageal squamous cell carcinoma (ESCC). METHODS: This retrospective study included patients with clinically staged T1‐4N0‐3M0 ESCC from 2014...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shueng, Pei‐Wei, Huang, Chun‐Chieh, Liu, Yu‐Ming, Wu, Yuan‐Hong, Huang, Pin‐I, Yen, Sang‐Hue, Lin, Kuan‐Heng, Hsu, Chen‐Xiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834687/ https://www.ncbi.nlm.nih.gov/pubmed/36351568 http://dx.doi.org/10.1111/1759-7714.14724

Ejemplares similares

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Volume-based algorithm of lung dose optimization in novel dynamic arc radiotherapy for esophageal cancer
por: Lin, Kuan-Heng, et al.
Publicado: (2021)

Prognostic Effect of the Dose of Radiation Therapy and Extent of Lymphadenectomy in Patients Receiving Neoadjuvant Chemoradiotherapy for Esophageal Squamous Carcinoma
por: Pai, Chu-Pin, et al.
Publicado: (2022)

Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer
por: Hsu, Chen-Xiong, et al.
Publicado: (2022)

Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma
por: Lin, Tian-Yun, et al.
Publicado: (2023)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
por: Yang, Yang, et al.
Publicado: (2020)

Integrating (18)F‐FDG PET/CT with lung dose‐volume for assessing lung inflammatory changes after arc‐based radiotherapy for esophageal cancer: A pilot study
por: Hsu, Chen‐Xiong, et al.
Publicado: (2022)

Integrating subvolume dose and myocardial perfusion imaging parameters to assess the impact of radiation therapy on heart function in breast cancer patients: A comparative analysis between left‐ and right‐sided breast cancer
por: Wang, Shan‐Ying, et al.
Publicado: (2023)

Comments on “Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis”
por: Tsang, Yuk‐Ming, et al.
Publicado: (2022)

Evaluation of the cardiac subvolume dose and myocardial perfusion in left breast cancer patients with postoperative radiotherapy: a prospective study
por: Wang, Shan-Ying, et al.
Publicado: (2023)

Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy
por: Deng, Yuxia, et al.
Publicado: (2017)

Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy
por: Pao, Tzu-Hui, et al.
Publicado: (2020)

Case report: Stereotactic body radiation therapy with 12 Gy for silencing refractory ventricular tachycardia
por: Huang, Shan-Hui, et al.
Publicado: (2022)

Evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma: A single institution experience
por: Ke, Te-Min, et al.
Publicado: (2018)

Study of preoperative diagnostic modalities in Chinese patients with superficial esophageal squamous cell carcinoma
por: Zeng, Ya-Ting, et al.
Publicado: (2022)

Survival benefit of surgery to patients with esophageal squamous cell carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2017)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
por: Ho, Yu-Chieh, et al.
Publicado: (2023)

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)

Toxicity risk of non-target organs at risk receiving low-dose radiation: case report
por: Shueng, Pei-Wei, et al.
Publicado: (2009)

Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
por: Luo, He-San, et al.
Publicado: (2019)

Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy
por: Ho, Yu-Chieh, et al.
Publicado: (2021)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Aortic Pseudoaneurysm Formation Following Concurrent Chemoradiotherapy And Metallic Stent Insertion in a Patient With Esophageal Cancer
por: Hou, Pei-Yu, et al.
Publicado: (2015)

Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
por: Huang, Yong, et al.
Publicado: (2023)

Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment
por: Feng, Wei-Hsiang, et al.
Publicado: (2022)

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
por: Oh, Dongryul, et al.
Publicado: (2016)

Galectin-1 Expression Is Associated with the Response and Survival Following Preoperative Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2021)

Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2017)

Impact of Varying Chest Wall Target Volume Delineation on Postmastectomy Radiation Therapy Outcomes in Breast Cancer Patients with Implant-Based Reconstruction
por: Hou, Pei-Yu, et al.
Publicado: (2023)

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
por: Lo, Chien-Ming, et al.
Publicado: (2021)

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014)

Expression of AKR1C3, β-Catenin and LEF1 in Esophageal Squamous Cell Carcinoma and the Relationship with Radiation Resistance
por: Xiong, Wei, et al.
Publicado: (2021)

Three‐dimensional conformal radiation therapy alone for esophageal squamous cell carcinoma: 10‐year survival outcomes
por: Fan, Xing‐Wen, et al.
Publicado: (2019)

Predicting Individual Survival after Curative Esophagectomy for Squamous Cell Carcinoma of Esophageal
por: Zhao, Zhiyong, et al.
Publicado: (2021)

Biomarkers of apoptosis and survival in esophageal squamous cell carcinoma
por: Takikita, Mikiko, et al.
Publicado: (2009)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
por: Qiu, Jianjian, et al.
Publicado: (2023)

Cardiac Function after Modern Radiation Therapy with Volumetric Modulated Arc Therapy or Helical Tomotherapy for Advanced Left-Breast Cancer Receiving Regional Nodal Irradiation
por: Hou, Pei-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_be1u3u4vnebh6un2epd59431t2